Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis – a critical review-Reference-Cited by-同舟云学术

Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis – a critical review

Published:2015-08-11 Issue:5 Volume:23 Page:1676-1698
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Singh Jagdeep,Garg Tarun,Rath Goutam,Goyal Amit K.

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/10717544.2015.1074765

Reference241 articles.

1. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations

2. Improved antimycobacterial activity of rifampin using solid lipid nanoparticles

3. Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells

4. Prediction of a Stable Microemulsion Formulation for the Oral Delivery of a Combination of Antitubercular Drugs Using ANN Methodology

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of solid lipid microparticles (SLMs) containing asiatic acid for topical treatment of acne: Characterization, stability, in vitro and in vivo anti-acne assessment;International Journal of Pharmaceutics;2024-04

2. Optical biosensing of multidrug-resistant tuberculosis (TB) genes;Optical Interactions with Tissue and Cells XXXV;2024-03-12

3. Nanoliposome Mediated Heavy Metal Detection;Biosurfactants: A Boon to Healthcare, Agriculture & Environmental Sustainability;2024-03-04

4. Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments;Clinical Microbiology Reviews;2023-12-20

5. Review of inhalable nanoparticles for the pulmonary delivery of anti-tuberculosis drugs;Pharmaceutical Development and Technology;2023-11-23